Signum Biosciences' Grant - V Round

Signum Biosciences raised a round of funding on September 14, 2009.

Signum Biosciences is a biotechnology company dedicated to developing small-molecule therapeutics derived from the Signal Transduction Modulation (STM) platform to modulate signal transduction imbalan…

Articles about Signum Biosciences' Grant - V Round: